Insilico Medicine, a clinical-stage biotechnology company powered by generative artificial intelligence (AI), today announced ...
For R&D leaders evaluating AI investments, I’d offer one piece of advice: Before spending more on models, look hard at your ...
SHANGHAI, SHANGHAI, CHINA, April 30, 2026 /EINPresswire.com/ -- In today’s life sciences industry, moving a drug ...
The fourth edition reflects both the maturation of Generative AI and our deeper understanding of its practical application in discovery and investigations. Since the third edition, AI systems have ...
Barbara Slusher explains the hit-to-lead optimization process, high-throughput screening, and the role of AI and organoids in ...
Organoids and engineered systems are transforming malaria research, improving drug discovery and understanding of Plasmodium ...
U.S. academic medical centers risk losing leadership in drug discovery and development as global competition—especially from ...
The Electronic Discovery Reference Model (EDRM) is undergoing a remodel, as myriad data sources, growing ESI, and new technology is turning e-discovery into a non-linear, complex process. [Editor’s ...
Scientists at Ames National Laboratory developed a new artificial intelligence (AI) tool that accelerates discovery of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results